
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Case Report: Transforming small cell lung cancer: two cases report and literature review - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="5BB8CA0281CDAC3307CA020019935871.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontonco">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12003138/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Oncology">
<meta name="citation_title" content="Case Report: Transforming small cell lung cancer: two cases report and literature review">
<meta name="citation_author" content="Jinlong Liu">
<meta name="citation_author_institution" content="Department of Oncology, Hebei General Hospital, Shijiazhuang, China">
<meta name="citation_author_institution" content="Graduate School, Hebei North University, Zhangjiakou, China">
<meta name="citation_author" content="Jing Ai">
<meta name="citation_author_institution" content="Department of Oncology, Hebei General Hospital, Shijiazhuang, China">
<meta name="citation_author_institution" content="Graduate School, North China University of Science and Technology, Tangshan, China">
<meta name="citation_author" content="Lize Zhao">
<meta name="citation_author_institution" content="Department of Vascular Surgery, Hebei General Hospital, Shijiazhuang, China">
<meta name="citation_author" content="Yimeng Qian">
<meta name="citation_author_institution" content="Department of Oncology, Hebei General Hospital, Shijiazhuang, China">
<meta name="citation_author_institution" content="Graduate School, Hebei North University, Zhangjiakou, China">
<meta name="citation_author" content="Qingxin Zhao">
<meta name="citation_author_institution" content="Department of Oncology, Hebei General Hospital, Shijiazhuang, China">
<meta name="citation_author_institution" content="Graduate School, Hebei North University, Zhangjiakou, China">
<meta name="citation_author" content="Chunling Ma">
<meta name="citation_author_institution" content="Department of Oncology, Hebei General Hospital, Shijiazhuang, China">
<meta name="citation_author" content="Yu Zhao">
<meta name="citation_author_institution" content="Department of Oncology, Hebei General Hospital, Shijiazhuang, China">
<meta name="citation_author" content="Jing Zhao">
<meta name="citation_author_institution" content="Department of Oncology, Hebei General Hospital, Shijiazhuang, China">
<meta name="citation_publication_date" content="2025 Apr 3">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="1573624">
<meta name="citation_doi" content="10.3389/fonc.2025.1573624">
<meta name="citation_pmid" content="40248195">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12003138/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12003138/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12003138/pdf/fonc-15-1573624.pdf">
<meta name="description" content="Transformation of non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a relatively rare event with an incidence of about 3%-14%. Due to the poor treatment outcomes and prognosis associated with this transformation, understanding ...">
<meta name="og:title" content="Case Report: Transforming small cell lung cancer: two cases report and literature review">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Transformation of non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a relatively rare event with an incidence of about 3%-14%. Due to the poor treatment outcomes and prognosis associated with this transformation, understanding ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12003138/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12003138">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fonc.2025.1573624"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fonc-15-1573624.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12003138%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12003138/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12003138/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12003138/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontonco.gif" alt="Frontiers in Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Oncology" title="Link to Frontiers in Oncology" shape="default" href="http://www.frontiersin.org/oncology" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Oncol</button></div>. 2025 Apr 3;15:1573624. doi: <a href="https://doi.org/10.3389/fonc.2025.1573624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fonc.2025.1573624</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Case Report: Transforming small cell lung cancer: two cases report and literature review</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Jinlong Liu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Jinlong Liu</span></h3>
<div class="p">
<sup>1</sup>
Department of Oncology, Hebei General Hospital, Shijiazhuang, China
</div>
<div class="p">
<sup>2</sup>
Graduate School, Hebei North University, Zhangjiakou, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jinlong Liu</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ai%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jing Ai</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jing Ai</span></h3>
<div class="p">
<sup>1</sup>
Department of Oncology, Hebei General Hospital, Shijiazhuang, China
</div>
<div class="p">
<sup>3</sup>
Graduate School, North China University of Science and Technology, Tangshan, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ai%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jing Ai</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Lize Zhao</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Lize Zhao</span></h3>
<div class="p">
<sup>4</sup>
Department of Vascular Surgery, Hebei General Hospital, Shijiazhuang, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lize Zhao</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qian%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yimeng Qian</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yimeng Qian</span></h3>
<div class="p">
<sup>1</sup>
Department of Oncology, Hebei General Hospital, Shijiazhuang, China
</div>
<div class="p">
<sup>2</sup>
Graduate School, Hebei North University, Zhangjiakou, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qian%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yimeng Qian</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Qingxin Zhao</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Qingxin Zhao</span></h3>
<div class="p">
<sup>1</sup>
Department of Oncology, Hebei General Hospital, Shijiazhuang, China
</div>
<div class="p">
<sup>2</sup>
Graduate School, Hebei North University, Zhangjiakou, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qingxin Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Chunling Ma</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Chunling Ma</span></h3>
<div class="p">
<sup>1</sup>
Department of Oncology, Hebei General Hospital, Shijiazhuang, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chunling Ma</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Yu Zhao</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Yu Zhao</span></h3>
<div class="p">
<sup>1</sup>
Department of Oncology, Hebei General Hospital, Shijiazhuang, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yu Zhao</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jing Zhao</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jing Zhao</span></h3>
<div class="p">
<sup>1</sup>
Department of Oncology, Hebei General Hospital, Shijiazhuang, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jing Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Department of Oncology, Hebei General Hospital, Shijiazhuang, China
</div>
<div id="aff2">
<sup>2</sup>
Graduate School, Hebei North University, Zhangjiakou, China
</div>
<div id="aff3">
<sup>3</sup>
Graduate School, North China University of Science and Technology, Tangshan, China
</div>
<div id="aff4">
<sup>4</sup>
Department of Vascular Surgery, Hebei General Hospital, Shijiazhuang, China
</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Sang-Won Um, Sungkyunkwan University, Republic of Korea</p></div>
<div class="fn" id="fn2">
<p>Reviewed by: Kaikai Zhao, Shandong Cancer Hospital, China</p>
<p>Maiqing Yang, Weifang People’s Hospital, China</p>
</div>
<div class="fn" id="fn001">
<sup>✉</sup><p class="display-inline">*Correspondence: Jing Zhao, <span>zzzjmail@163.com</span>
</p>
</div>
<div class="fn" id="fn003"><p>†These authors have contributed equally to this work and share first authorship</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 9; Accepted 2025 Mar 17; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 Liu, Ai, Zhao, Qian, Zhao, Ma, Zhao and Zhao</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12003138  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40248195/" class="usa-link">40248195</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Transformation of non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a relatively rare event with an incidence of about 3%-14%. Due to the poor treatment outcomes and prognosis associated with this transformation, understanding its underlying mechanisms is crucial for improving the diagnosis, management, and prognosis of transformed small cell lung cancer (T-SCLC). In this paper, we present two cases of T-SCLC and review the molecular mechanisms, clinical features, and treatment strategies post-transformation. We emphasize the importance of considering pathological transformation in cases of resistance to NSCLC treatment, monitoring changes in tumor markers, and conducting a re-biopsy. Finally, we propose effective treatment measures for managing T-SCLC.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> transformed small cell lung cancer, tumor markers, re-biopsy, pathological transformation, drug resistance</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>According to the Global Tumor Epidemiology Statistics (GLOBOCAN), lung cancer ranks first among malignant tumors in China in terms of both new cases and deaths (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>). It is classified into two major subtypes based on histology: NSCLC and SCLC. SCLC is a neuroendocrine tumor characterized by high aggressiveness, malignancy, and poor prognosis. During the progression of NSCLC, its histological type can transform into SCLC, a phenomenon known as T-SCLC. Although SCLC and T-SCLC share similar pathological morphology, molecular features, clinical manifestations, and drug sensitivity, their pathogenesis and tumor microenvironment differ significantly. Effective treatments for T-SCLC remain limited, and its prognosis is poor. In this paper, we present two cases of T-SCLC and provide a comprehensive summary of the clinical features, mechanisms, predictive factors, and treatment strategies associated with SCLC transformation. Our findings emphasize the importance of re-biopsy in managing drug resistance and the necessity of dynamic monitoring of tumor marker changes. Furthermore, we propose an effective treatment approach for T-SCLC, offering new perspectives for clinical diagnosis and management.</p></section><section id="s2"><h2 class="pmc_sec_title">Case presentation</h2>
<section id="s2_1"><h3 class="pmc_sec_title">Case 1</h3>
<p>In April 2021, a 61-year-old female patient was admitted for evaluation of chest tightness and a cough. Physical examination revealed diminished breath sounds, and dry rales were heard in the right lower lung. The patient had grade 3 hypertension (very high risk), no other diseases, no family history of tumors, and no history of smoking. Chest CT revealed a mass in the lower lobe of the right lung with a distal obstructive lesion, measuring 83 mm in maximum diameter, suspected to be lung cancer (<a href="#f1" class="usa-link">
<strong>Figure 1A</strong>
</a>). At the same time, multiple enlarged lymph nodes were noted in the right supraclavicular fossa, mediastinum, and the right hilar region of the lung. Brain MRI revealed brain metastasis in the left occipital lobe. Tumor markers were evaluated, and all results were within the normal range: SCC 1.830 ng/mL (normal range: &lt;2.5 ng/mL), Pro-GRP 50.40 pg/mL (normal range: &lt;74.4 pg/mL), CEA 3.180 ng/mL (normal range: &lt;5.5 ng/mL), CYFRA21-1 2.150 ng/mL (normal range: &lt;3.3 ng/mL), and NSE 8.530 ng/mL (normal range: 0–15 ng/mL). An ultrasound-guided aspiration biopsy of a right cervical root lymph node was performed on April 15, 2021. Tumor tissues and their invasive tissues were collected by fine needle aspiration (FNA) and processed into formalin-fixed, paraffin-embedded (FFPE) blocks for histopathological diagnosis and molecular testing. Postoperative pathology confirmed adenocarcinoma of the lower lobe of the right lung (T2N3M1, stage IV). Immunohistochemical analysis showed: CK7 (+), CK20 (-), Villin (-), TTF-1 (+), Napsin A (+), CK5/6 (-), CR (-), CEA (+), EMA (+), and Ki-67 (approximately 20%+) (<a href="#f2" class="usa-link">
<strong>Figure 2A</strong>
</a>). Subsequently, genetic testing using high-throughput sequencing identified an EGFR exon 21 L858R mutation with 80% abundance, accompanied by TP53 and RB1 mutations. The patient subsequently took 80 mg of osimertinib orally daily for 2 years, with regular follow-ups during this period, achieving a clinical complete remission (cCR) (<a href="#f1" class="usa-link">
<strong>Figure 1B</strong>
</a>). A chest CT review in April 2023 showed an enlarged tumor with a maximum diameter of 21 mm, and efficacy was assessed as progressive disease (PD) according to RECIST criteria. (<a href="#f1" class="usa-link">
<strong>Figure 1C</strong>
</a>). A repeat genetic test indicated the EGFR exon 21 L858R mutation with an abundance of 23.25%. Therefore, the treatment was switched to furmonertinib 80 mg per day. A follow-up chest CT in February 2024 showed that the patient’s tumor had enlarged compared to the previous scan, with a maximum diameter of 29 mm. The efficacy assessment was recorded as PD (<a href="#f1" class="usa-link">
<strong>Figure 1D</strong>
</a>). Therefore, the patient was switched to PC (pemetrexed + carboplatin) chemotherapy combined with sintilimab immunotherapy and received bevacizumab for anti-angiogenesis therapy until June 2024. The June 2024 CT scan showed an increase in the size of the lung tumor compared to the February 2024 scan, with a maximum diameter of 37 mm. The efficacy assessment was recorded as PD (<a href="#f1" class="usa-link">
<strong>Figure 1E</strong>
</a>). Tumor markers were also assessed: Pro-GRP 120.80 pg/mL (normal range: &lt;74.4 pg/mL), NSE 17.610 ng/mL (normal range: 0–15 ng/mL), CEA 3.020 ng/mL (normal range: &lt;5.5 ng/mL), CYFRA21-1 3.150 ng/mL (normal range: &lt;3.3 ng/mL), SCC 2.130 ng/mL (normal range: &lt;2.5 ng/mL), CA 19-9 5.800 U/mL (normal range: &lt;34 U/mL), CA 125 16.620 U/mL (normal range: &lt;35 U/mL), and CA 15-3 24.980 U/mL (normal range: &lt;25 U/mL). Pro-GRP and NSE were elevated, but the other markers were within the normal range (<a href="#f3" class="usa-link">
<strong>Figures 3A, B</strong>
</a>). To further clarify the pathological diagnosis, on June 28, 2024, we performed a CT-guided percutaneous lung aspiration biopsy on the patient. Biopsy pathology revealed infiltrative carcinoma, with immunohistochemical staining as follows: CKpan(+), TTF-1(+), Syn(+), CgA(partial+), Ki-67(approximately 70%+), CD56(+), CK5/6(-), Vimentin(-), P40(-), CK7(partial+), and NapsinA(-) (<a href="#f2" class="usa-link">
<strong>Figure 2B</strong>
</a>). Combined with immunohistochemical staining results, the diagnosis of small cell lung cancer transformation was confirmed in the patient. Therefore, on July 3, 2024; July 29, 2024; August 19, 2024; and October 11, 2024, the patient underwent four cycles of durvalumab immunotherapy in combination with the EP regimen (etoposide + cisplatin). After chemotherapy, the patient experienced poor tolerance, exhibiting atopic dermatitis and significant bone marrow suppression. Following aggressive symptomatic treatment, the patient’s symptoms were relieved. Volumetric-modulated arc therapy was delivered using a linear accelerator with 6-MV photons, delivering a total dose of 60 Gy in 30 fractions over six weeks, from July 22 to September 3, 2024. On follow-up CT after radiotherapy, the tumor was significantly reduced, and the efficacy evaluation showed a partial response (PR) (<a href="#f1" class="usa-link">
<strong>Figure 1F</strong>
</a>). After treatment, the patient’s mental status and appetite were stable, and her condition remained stable with regular follow-ups (<a href="#f4" class="usa-link">
<strong>Figure 4A</strong>
</a>).</p>
<figure class="fig xbox font-sm" id="f1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12003138_fonc-15-1573624-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3245/12003138/3dd82ee703b0/fonc-15-1573624-g001.jpg" loading="lazy" height="347" width="779" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Computed tomography. <strong>(A)</strong> There is an obvious occupying lesion in the right lower lobe. <strong>(B)</strong> Targeted treatment with osimertinib resulted in a cCR. <strong>(C)</strong> Two years later, a space-occupying lesion reappeared, and the treatment efficacy was evaluated as PD. <strong>(D)</strong> Targeted treatment with furmonertinib resulted in disease progression. <strong>(E)</strong> Treatment with sindilizumab combined with bevacizumab and PC chemotherapy regimen resulted in disease progression. <strong>(F)</strong> Treatment with duvatolimab combined with EP chemotherapy regimen and local radiotherapy resulted in a PR.</p></figcaption></figure><figure class="fig xbox font-sm" id="f2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12003138_fonc-15-1573624-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3245/12003138/f13512bd535c/fonc-15-1573624-g002.jpg" loading="lazy" height="563" width="773" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The hematoxylin and eosin (HE) and immunohistochemical (IHC) pictures: <strong>(A)</strong> Biopsy specimen from the right cervical lymph node revealed lung adenocarcinoma with HE staining and IHC staining for TTF-1, Napsin A and Ki-67 (20%+). <strong>(B)</strong> The second biopsy of the lung mass revealed SCLC with HE staining and IHC staining for CD56, Syn and Ki-67 (70%+). <strong>(C)</strong> Biopsy specimen from the lung mass revealed lung adenocarcinoma with HE staining and IHC staining for TTF-1, Napsin A and Ki-67 (30%+). <strong>(D)</strong> The second biopsy of the left supraclavicular lymph nodes revealed SCLC with HE and IHC staining for CD56, Syn and Ki-67 (80%+). All pictures were acquired with a light microscope at 100x magnification.</p></figcaption></figure><figure class="fig xbox font-sm" id="f3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12003138_fonc-15-1573624-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3245/12003138/ad3143691dba/fonc-15-1573624-g003.jpg" loading="lazy" height="427" width="740" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The profile of NSE and Pro-GRP in serum. <strong>(A, B)</strong> Case 1, <strong>(C, D)</strong> Case 2. NSE normal range: 0–15 ng/mL, Pro-GRP normal range: &lt;74.4 pg/mL.</p></figcaption></figure><figure class="fig xbox font-sm" id="f4"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12003138_fonc-15-1573624-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3245/12003138/d049aeb7ae8a/fonc-15-1573624-g004.jpg" loading="lazy" height="615" width="738" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/f4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Patient‘s treatment history and medication details. <strong>(A)</strong> Case 1 <strong>(B)</strong> Case 2.</p></figcaption></figure></section><section id="s2_2"><h3 class="pmc_sec_title">Case 2</h3>
<p>On October 3, 2022, a 64-year-old man was found to have an irregular nodular shadow, with a maximum diameter of 22 mm, in the apical segment of the right upper lobe, suspected to be a malignant tumor (<a href="#f5" class="usa-link">
<strong>Figure 5A</strong>
</a>). Multiple enlarged lymph nodes were also noted in the mediastinum and right hilar region on a chest examination. He was later admitted for evaluation. Physical examination revealed clear breath sounds in both lungs, with no dry or wet rales. The patient had previously undergone inguinal hernia repair, no other diseases and no family history of tumors. He had a history of heavy smoking. A CT-guided lung mass biopsy was performed on November 7, 2022. Postoperative pathology confirmed a right upper lobe adenocarcinoma (cT4N3M0, stage IIIC). Immunohistochemical analysis showed: CKpan (+), Vimentin (-), CK7 (+), CK20 (-), Villin (-), TTF-1 (+), Napsin A (+), CK5/6 (-), P40 (-), and Ki-67 (approximately 30%+) (<a href="#f2" class="usa-link">
<strong>Figure 2C</strong>
</a>). Later, genetic testing by high-throughput sequencing revealed mutations in PIK3CA and TP53, while EGFR, RB1, ALK, BRAF, KRAS, NRAS, MET, and ROS1 were wild-type. Due to the patient’s emaciation and poor physical condition, he was deemed unable to tolerate concurrent radiochemotherapy. As a result, the patient received 0.8 g of pemetrexed and 120 mg of cisplatin, administered over six cycles of chemotherapy. However, during the course of treatment, the patient contracted COVID-19, and chemotherapy was temporarily suspended. Chest CT on June 23, 2023, showed a reduction in size of the apical portion of the right upper lobe, with a maximum diameter of 11 mm (<a href="#f5" class="usa-link">
<strong>Figure 5D</strong>
</a>). The right hilar and mediastinal lymph nodes were also smaller. However, a metastatic tumor measuring 44 mm in maximum diameter was found in the right lower chest wall, involving the right 10th rib (<a href="#f5" class="usa-link">
<strong>Figure 5B</strong>
</a>). The efficacy assessment was recorded as PD. The patient underwent sequential chest radiotherapy for right lung cancer using a linear accelerator with 6-MV photons, delivering a total dose of 60 Gy in 30 fractions over 6 weeks, from October 23, 2023, to December 7, 2023. In November 2023, the patient experienced memory loss, dizziness, and headache and underwent evaluation for these symptoms. Cranial MRI revealed multiple intracranial metastases and whole-brain radiotherapy was initiated from December 13, 2023, to January 9, 2024, delivering a total dose of 40 Gy in 20 fractions. After treatment, the patient’s dizziness and headache resolved. A CT scan in January 2024 revealed an irregularly shaped soft tissue mass on the right side of the T11 and T12 vertebrae, with a maximum diameter of 41 mm. Metastatic tumor with bone destruction of the adjacent T11 and T12 vertebrae was suspected. The efficacy evaluation was PD. Due to severe pain and difficulty lying down caused by metastases in the right lower chest wall and thoracic vertebrae, radiotherapy was administered to these sites from January 18, 2024, to February 8, 2024, with a total dose of 54 Gy in 18 fractions. After radiotherapy, the patient’s pain was relieved, mental status improved, and appetite was good. As the patient was unable to tolerate intravenous chemotherapy due to poor physical condition, maintenance treatment with anlotinib combined with atezolizumab was administered every three weeks throughout and after the radiotherapy period. In May 2024, the patient was found to have a hard mass in the neck that gradually increased in size, with a maximum diameter of 41 mm (<a href="#f5" class="usa-link">
<strong>Figure 5C</strong>
</a>). Tumor control was poor. A CT scan of the abdominopelvic region was performed on June 27, 2024. The metastases in the right lower chest wall were smaller compared to previous scans, with a maximum diameter of 21 mm (<a href="#f5" class="usa-link">
<strong>Figure 5E</strong>
</a>). Metastases in the T11 and T12 vertebrae showed no significant changes. Multiple subcutaneous soft tissue metastases were observed in the abdominopelvic wall. Bilateral adrenal metastases were present, along with multiple soft tissue density shadows in the mesenteric area, paracolon, pararenal region, between the pancreas and stomach, retroperitoneal area, and pelvis, suggestive of metastatic tumors. Tumor progression was considered, and the efficacy evaluation was assessed as PD. Further assessment of tumor markers revealed the following results: CEA 639.800 ng/mL (normal range: &lt;5.5 ng/mL), NSE 69.290 ng/mL (normal range: 0–15 ng/mL), Pro-GRP 2286.00 pg/mL (normal range: &lt;74.4 pg/mL), CYFRA21-1 14.270 ng/mL (normal range: &lt;3.3 ng/mL), SCC 2.230 ng/mL (normal range: &lt;2.5 ng/mL), CA125 15.090 U/mL (normal range: &lt;35 U/mL), and CA199 6.470 U/mL (normal range: &lt;34 U/mL). CEA, NSE, Pro-GRP, CYFRA21-1, and SCC were elevated, while CA125 and CA199 remained within the normal range (<a href="#f3" class="usa-link">
<strong>Figures 3C, D</strong>
</a>). The patient’s condition worsened, and to further clarify the diagnosis, an ultrasound-guided biopsy of the left supraclavicular lymph nodes was performed on June 27, 2024. The pathological examination showed infiltrative carcinoma with extensive necrosis. Immunohistochemical staining revealed the following: CKpan (+), Vimentin (-), CK7 (partially +), NapsinA (-), TTF-1 (+), P40 (-), P63 (-), Syn (+), CgA (-), CD56 (+), and Ki-67 (approximately 80%+) (<a href="#f2" class="usa-link">
<strong>Figure 2D</strong>
</a>). Combined with immunohistochemical staining results, a diagnosis of small cell carcinoma transformation was confirmed. The patient underwent two cycles of chemotherapy with the EC regimen (etoposide + carboplatin) on July 3, 2024, and August 2, 2024. Additionally, on July 3, 2024, August 2, 2024, October 10, 2024, and November 6, 2024, the patient received four cycles of atezolizumab combined with anlotinib. From September 25, 2024, to November 5, 2024, the patient underwent radiotherapy to the bilateral cervical lymph nodes and bilateral supraclavicular lymph nodes, receiving a total dose of 60 Gy in 30 fractions. The patient developed myelosuppression following radiotherapy, which resolved after prompt symptomatic treatment. On December 28, 2024, a follow-up CT scan showed a significant reduction in the size of the neck mass, with a maximum diameter of 24 mm, indicating a PR to treatment (<a href="#f5" class="usa-link">
<strong>Figure 5F</strong>
</a>). The patient is currently under regular follow-up, with stable disease (<a href="#f4" class="usa-link">
<strong>Figure 4B</strong>
</a>).</p>
<figure class="fig xbox font-sm" id="f5"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12003138_fonc-15-1573624-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3245/12003138/056832affcfb/fonc-15-1573624-g005.jpg" loading="lazy" height="430" width="779" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/f5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Computed tomography. <strong>(A)</strong> Obvious occupying lesion in the right upper lung lobe. <strong>(B)</strong> Metastasis occurred in the right lower chest wall and was evaluated as PD. <strong>(C)</strong> Metastasis occurred in the neck and was evaluated as PD. <strong>(D)</strong> After the PP chemotherapy regimen, the lesion decreased in size. <strong>(E)</strong> Radiotherapy was administered to a mass in the right lower chest wall, resulting in a significant reduction in size. <strong>(F)</strong> The neck mass was treated with radiotherapy, and the efficacy was evaluated as PR.</p></figcaption></figure></section></section><section id="s3"><h2 class="pmc_sec_title">Discussion</h2>
<p>Currently, two main hypotheses exist regarding the pathogenesis of SCLC transformation. Histological transformation of NSCLC to SCLC is generally considered a rare mechanism of acquired resistance to EGFR inhibitors (<a href="#B2" class="usa-link" aria-describedby="B2">2</a>). A review of the relevant literature in PubMed revealed 17 previously reported cases of sequential SCLC after adenocarcinoma, involving 7 male and 10 female patients. Ten of the patients were nonsmokers and six were smokers, with a median age of 50-60 years. All patients were treated with EGFR-TKIs and eventually underwent transformation into small cell lung cancer, with a median survival of approximately 6 to 9 months after transformation (<a href="#T1" class="usa-link">
<strong>Table 1</strong>
</a>). Approximately 3–10% of patients with EGFR-mutant NSCLC experience SCLC transformation following treatment with EGFR-TKIs (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>). This transformation is strongly associated with inactivating mutations in the RB1 and TP53 genes, with triple-mutant adenocarcinomas (EGFR/RB1/TP53) being at higher risk of transformation to SCLC (<a href="#B7" class="usa-link" aria-describedby="B7">7</a>). The risk of transformation significantly increases to 18% in patients with an EGFR/TP53/RB1 triple mutation (<a href="#B20" class="usa-link" aria-describedby="B20">20</a>). In Case 1, genetic testing at the time of initial treatment revealed EGFR, RB1, and TP53 mutations. After more than two years of treatment with osimertinib, pathological transformation occurred. Therefore, during clinical diagnosis and treatment, the presence of triple mutations in genetic testing should raise suspicion of potential SCLC transformation in the later stages of treatment resistance. The second hypothesis suggests that SCLC transformation can occur in ALK inhibitor-treated lung cancers or in wild-type EGFR or ALK NSCLC treated with immunotherapy; however, the exact mechanism remains unclear. In Case 2, initial genetic testing showed wild-type EGFR and RB1, with only a TP53 mutation present. Despite this, the patient eventually underwent pathological transformation. The underlying mechanism remains uncertain, and further follow-up studies are needed to elucidate the process. Small cell lung cancer (SCLC) transformation is most common in EGFR-mutant NSCLC, particularly in patients with concomitant TP53 and RB1 loss of function. NSCLC with alterations in other driver genes (e.g., ALK, ROS1, RET, KRAS, etc.) may also undergo transformation, but this occurs rarely (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>–<a href="#B21" class="usa-link" aria-describedby="B21">21</a>).</p>
<section class="tw xbox font-sm" id="T1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Cases of small cell lung cancer transformed from lung adenocarcinoma.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="middle" align="center" rowspan="1" colspan="1">Case</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Age</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Sex</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Smoking history (pack years)</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Initial histology/genetic mutation</th>
<th valign="middle" align="center" rowspan="1" colspan="1">TNM</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Treatment</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Transformed histology/ genetic mutation</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Treatment after transformation</th>
<th valign="middle" align="center" rowspan="1" colspan="1">OS after transformation</th>
</tr></thead>
<tbody>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Otoshi, Ryota, et al. (<a href="#B3" class="usa-link" aria-describedby="B3">3</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">68</td>
<td valign="middle" align="center" rowspan="1" colspan="1">M</td>
<td valign="middle" align="center" rowspan="1" colspan="1">40</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del, EGFR T790M mutation</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Osimertinib; erlotinib; osimertinib; carboplatin, paclitaxel, docetaxel, pemetrexed; S-1 monotherapy</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Hui, Monalisa, et al. (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">46</td>
<td valign="middle" align="center" rowspan="1" colspan="1">M</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Smoker (specific pack-years NM)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Pemetrexed, carboplatin, zoledronate; gefitinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="center" colspan="1">Ahn, Soomin, et al. (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">57</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR exon 21 L858R</td>
<td valign="middle" align="center" rowspan="1" colspan="1">T2N0M0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Operation, paclitaxel, carboplatin; iressa; afatinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR exon 21 L858R</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EP</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">55</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">T2N3M1</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Iressa</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EP</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Digiacomo, Nunzio, et al. (<a href="#B6" class="usa-link" aria-describedby="B6">6</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">50</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">30</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR exon 18 mutation</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Osimertinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, PDL1, EGFR exon 18 mutation, PIK3CA mutation</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EC; atezolizumab</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Lyu, Heng-Xu, et al. (<a href="#B7" class="usa-link" aria-describedby="B7">7</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">65</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR exon 21 L858R, PTEN mutation</td>
<td valign="middle" align="center" rowspan="1" colspan="1">T2N2M1</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Osimertinib, anlotinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR exon 21 L858R, PTEN mutation</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Serplulimab, EC; radiotherapy</td>
<td valign="middle" align="center" rowspan="1" colspan="1">About 6 months</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Tokaca, Nadza, et al. (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">60</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">T1aN0M1a</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Gefitinib; radiotherapy</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EC; CAV; Nivolumab</td>
<td valign="middle" align="center" rowspan="1" colspan="1">About 20 months</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Liu, Hao, et al. (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">63</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR mutation</td>
<td valign="middle" align="center" rowspan="1" colspan="1">T2N2M1</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Gefitinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Refuse treatment</td>
<td valign="middle" align="center" rowspan="1" colspan="1">About 1 months</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Wang, Yi, et al. (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">48</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del, EGFR T790M mutation</td>
<td valign="middle" align="center" rowspan="1" colspan="1">T2aN0M0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Operation; paclitaxel, nedaplatin; gefitinib; osimertinib </td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR 19 del, PIK3CA mutation</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EP</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Xue, Shuping, et al. (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">49</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">pT2N2M0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Operation; PP; Gefitinib; osimertinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Zhang, Cuicui, et al. (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">56</td>
<td valign="middle" align="center" rowspan="1" colspan="1">M</td>
<td valign="middle" align="center" rowspan="1" colspan="1">50</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del, EGFR amp, RB1 and TP53 mutations</td>
<td valign="middle" align="center" rowspan="1" colspan="1">cT3N3M1a</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Icotinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR 19 del, EGFR amp, RB1 and TP53 mutations, MSH6, PMS2 amp; PD-L1(–); TMB of 15.32Muts/Mb</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EC; docetaxel, icotinib, irinotecan, anlotinib, pabolizumab</td>
<td valign="middle" align="center" rowspan="1" colspan="1">About 9 months</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Lin, Quan, et al. (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">49</td>
<td valign="middle" align="center" rowspan="1" colspan="1">M</td>
<td valign="middle" align="center" rowspan="1" colspan="1">20</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR exon 21 L858R,</td>
<td valign="middle" align="center" rowspan="1" colspan="1">cT2aN2M1a</td>
<td valign="middle" align="center" rowspan="1" colspan="1">PP; gefitinib; cisplatin; docetaxel </td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EP</td>
<td valign="middle" align="center" rowspan="1" colspan="1">About 8 months</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Chowaniecova, Gabriela, et al. (<a href="#B14" class="usa-link" aria-describedby="B14">14</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">67</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Afatinib; radiotherapy; PC; Osimertinib; docetaxel</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EC; topotecan; erlotinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">About 7 months</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Zhai, Xiaoqian, et al. (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">43</td>
<td valign="middle" align="center" rowspan="1" colspan="1">M</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del, high PD-L1 (80.9%) expression</td>
<td valign="middle" align="center" rowspan="1" colspan="1">pT2bN0M0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Operation; gefitinib; radiotherapy; pembrolizumab, pemetrexed; osimertinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR 19 del, TP53 and RB1 mutation</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EP; anlotinib; gefitinib; EC, durvalumab</td>
<td valign="middle" align="center" rowspan="1" colspan="1">About 21 months</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Yang, Meng-Hang, et al. (<a href="#B16" class="usa-link" aria-describedby="B16">16</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">50</td>
<td valign="middle" align="center" rowspan="1" colspan="1">M</td>
<td valign="middle" align="center" rowspan="1" colspan="1">10</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR 19 del</td>
<td valign="middle" align="center" rowspan="1" colspan="1">T4N3M1b</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Erlotinib; toripalimab, PC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR 19del and T790M (+)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EC; osimertinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Li, Xiaoxuan, et al. (<a href="#B17" class="usa-link" aria-describedby="B17">17</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">71</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR exon 21 L858R</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Osimertinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC, EGFR 19del, TP53 missense mutation, RB1 truncating mutation, EGFR amp, KIT amp,</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Anlotinib, aumolertinib; EP, adebrelimab; osimertinib, EP, adebrelimab</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Liu, Yangyang, et al. (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>)</td>
<td valign="middle" align="center" rowspan="1" colspan="1">38</td>
<td valign="middle" align="center" rowspan="1" colspan="1">M</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR exon 21 L858R</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
<td valign="middle" align="center" rowspan="1" colspan="1">PP, erlotinib</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EP</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NM</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Our case</td>
<td valign="middle" align="center" rowspan="1" colspan="1">61</td>
<td valign="middle" align="center" rowspan="1" colspan="1">F</td>
<td valign="middle" align="center" rowspan="1" colspan="1">0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, EGFR exon 21 L858R, TP53, RB1</td>
<td valign="middle" align="center" rowspan="1" colspan="1">T2N3M1</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Osimertinib; furmonertinib; PC, sintilimab; bevacizumab</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EP; durvalumab; radiotherapy</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="middle" align="center" rowspan="1" colspan="1">Our case</td>
<td valign="middle" align="center" rowspan="1" colspan="1">64</td>
<td valign="middle" align="center" rowspan="1" colspan="1">M</td>
<td valign="middle" align="center" rowspan="1" colspan="1">15</td>
<td valign="middle" align="center" rowspan="1" colspan="1">ADC, PIK3CA, TP53</td>
<td valign="middle" align="center" rowspan="1" colspan="1">cT4N3M0</td>
<td valign="middle" align="center" rowspan="1" colspan="1">PP; radiotherapy; anlotinib, atezolizumab</td>
<td valign="middle" align="center" rowspan="1" colspan="1">SCLC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">EC, atezolizumab, anlotinib; radiotherapy</td>
<td valign="middle" align="center" rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn4"><p>M, male; F, female; ADC, adenocarcinoma; SCLC, small cell lung cancer; NM, not mentioned; NA, not applicable; EC, etoposide plus carboplatin; EP, etoposide plus cisplatin; PP, pemetrexed plus cisplatin; amp, amplification; PC, pemetrexed plus carboplatin; OS, overall survival; TMB, tumor mutational burden; CAV, cyclophosphamide, doxorubicin plus vincristine.</p></div></div></section><p>Pathological transformation should be considered in NSCLC patients who show insensitivity to treatment during clinical practice. Additionally, a rapid increase in peripheral serum NSE and Pro-GRP levels has been identified as a predictive marker for pathological transformation to SCLC (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>, <a href="#B22" class="usa-link" aria-describedby="B22">22</a>). In the two cases we reported, disease progression was observed during treatment, accompanied by a rising trend in NSE and Pro-GRP levels in the patient’s serum. Subsequent biopsies confirmed pathological transformation in both cases. Therefore, dynamic monitoring of NSE and Pro-GRP levels during treatment, combined with timely biopsy when necessary, is crucial for improving diagnosis, treatment, and patient prognosis.</p>
<p>T-SCLC typically exhibits rapid disease progression and poor prognosis due to its aggressiveness and the limited availability of effective therapeutic options, making the search for new treatments essential. T-SCLC shares similar pathological morphology, molecular features, clinical presentations, and drug sensitivity with SCLC, suggesting that they may benefit from similar therapeutic strategies (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>). One potential mechanism underlying the histological transition from EGFR-mutant NSCLC to SCLC is lineage plasticity, which enables the dedifferentiation of cancer cells from an epithelial to a neuroendocrine lineage in response to EGFR-TKI treatment (<a href="#B24" class="usa-link" aria-describedby="B24">24</a>). Neuroendocrine differentiation is also observed after pathological transformation of NSCLC, and this phenotype tends to be sensitive to chemotherapy (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>). Platinum-based chemotherapy (cisplatin or carboplatin) combined with etoposide remains the primary treatment regimen for most patients diagnosed with T-SCLC (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>). A retrospective study used platinum-etoposide to treat transformed SCLC, in which the clinical response rate among 46 patients reached 54% at transformation, with the median progression-free survival of only 3.4 months (range: from 2.4 to 5.4 months) (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>). In addition to EC regimen chemotherapy, treatment options for T-SCLC include paclitaxel-based chemotherapy, anti-angiogenic therapy with anlotinib, and local radiotherapy (<a href="#B25" class="usa-link" aria-describedby="B25">25</a>, <a href="#B26" class="usa-link" aria-describedby="B26">26</a>). A real-world study included 29 patients who developed SCLC transformation following EGFR-targeted therapy. The analysis indicated that compared to chemotherapy alone, the combination of chemotherapy and targeted therapy improved objective response rates and PFS, although it did not significantly extend OS. Anti-angiogenic therapy and local radiotherapy can prolong OS after transformation (<a href="#B26" class="usa-link" aria-describedby="B26">26</a>). A previous study reported 18 patients who received anti-angiogenic agents in the first- or second-line after SCLC transformation with anlotinib being most frequently administered. The study demonstrated that anlotinib can treat transformed SCLC patients and achieve longer OS than those who did not receive anti-angiogenic agents (<a href="#B26" class="usa-link" aria-describedby="B26">26</a>). Another study validated this result using EGFR mutant transformed SCLC patients and achieved an ORR of 66.7% and a median PFS of 6.2 months (<a href="#B27" class="usa-link" aria-describedby="B27">27</a>). Tomic, Kresimir, et al., reported that the median time to T-SCLC transformation in EGFR-mutant NSCLC patients treated with TKIs is approximately 17 months, with a median overall survival of 10 months (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>). For patients whose NSCLC transformed to SCLC following immunotherapy, overall survival times varied widely, ranging from 2 to 16 months (<a href="#B29" class="usa-link" aria-describedby="B29">29</a>). In case 1, a pathological transformation was observed during re-examination after more than 2 years of treatment with osimertinib. However, we considered that the patient’s pathological transformation might have occurred earlier. Therefore, re-biopsy is necessary in cases of EGFR-TKI resistance. Zhang, Chan-Yuan, et al. retrospectively analyzed the efficacy of immunotherapy combined with chemotherapy in T-SCLC. The results indicated that this approach could be a therapeutic option for patients with T-SCLC and might benefit from the addition of anti-angiogenic therapy (<a href="#B30" class="usa-link" aria-describedby="B30">30</a>). Case 1 was treated with 4 cycles of immunotherapy and anti-angiogenic therapy combined with EP regimen chemotherapy after the diagnosis of T-SCLC. Due to the limited lung lesions in case 1, local tumor radiotherapy was administered to control the lesions. Follow-up CT showed that the lesions remained controlled, and the patient’s general condition was still good, suggesting the treatment was effective. Case 2 was treated with the EC regimen chemotherapy for 2 cycles after the diagnosis of T-SCLC, and the tumor regressed significantly. Both of our patients were treated aggressively, and tumor control was achieved. Therefore, we believe that the treatment of T-SCLC should include chemotherapy based on the EC regimen, combined with immune and anti-angiogenic therapy, and radiotherapy should be administered to local metastatic foci. If the patient’s physical condition permits, it is recommended to actively administer comprehensive treatment to improve the quality of life and the patient’s prognosis.</p></section><section id="s4"><h2 class="pmc_sec_title">Conclusion</h2>
<p>This study presents two cases of lung adenocarcinoma in which patients experienced disease progression after different treatments, both of which were subsequently pathologically confirmed to have transformed into SCLC. These findings emphasize the importance of dynamic tumor marker monitoring and re-biopsy in cases of NSCLC treatment resistance. Compared to typical SCLC, T-SCLC progresses more rapidly. Upon clinical confirmation of SCLC transformation, early development of an individualized treatment plan, along with regular follow-ups to promptly adjust therapeutic strategies, is crucial. The limitations of current diagnostic and therapeutic approaches highlight the urgent need for improved T-SCLC guidelines and clinical practices. A multidisciplinary approach is vital to better understand the disease and tailor effective treatment strategies.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by Government-funded training program for clinical excellence in 2022. (Grant No.202224).</p></section><section id="s5"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p></section><section id="s6"><h2 class="pmc_sec_title">Ethics statement</h2>
<p>The studies involving humans were approved by Hebei General Hospital Ethics Committee/Hebei General Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The human samples used in this study were acquired from primarily isolated as part of your previous study for which ethical approval was obtained. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p></section><section id="s7"><h2 class="pmc_sec_title">Author contributions</h2>
<p>JL: Writing – original draft, Writing – review &amp; editing. JA: Writing – original draft, Writing – review &amp; editing. LZ: Writing – review &amp; editing, Writing – original draft. YQ: Writing – review &amp; editing. QZ: Writing – review &amp; editing. CM: Resources, Writing – original draft, Writing – review &amp; editing. YZ: Writing – original draft, Writing – review &amp; editing, Resources. JZ: Writing – original draft, Writing – review &amp; editing.</p></section><section id="s9"><h2 class="pmc_sec_title">Conflict of interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s10"><h2 class="pmc_sec_title">Generative AI statement</h2>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></section><section id="s11"><h2 class="pmc_sec_title">Publisher’s note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-A Cancer J Clin. (2024) 74:229–63. doi:  10.3322/caac.21834
</cite> [<a href="https://doi.org/10.3322/caac.21834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38572751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA-A%20Cancer%20J%20Clin&amp;title=Global%20cancer%20statistics%202022:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries&amp;author=F%20Bray&amp;author=M%20Laversanne&amp;author=H%20Sung&amp;author=J%20Ferlay&amp;author=RL%20Siegel&amp;volume=74&amp;publication_year=2024&amp;pmid=38572751&amp;doi=10.3322/caac.21834&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Xie T, Li Y, Ying J, Cai W, Li J, Lee KY, et al. Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD). Trans Lung Cancer Res. (2020) 9:2428–39. doi:  10.21037/tlcr-20-1278
</cite> [<a href="https://doi.org/10.21037/tlcr-20-1278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7815376/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33489804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trans%20Lung%20Cancer%20Res&amp;title=Whole%20exome%20sequencing%20(WES)%20analysis%20of%20transformed%20small%20cell%20lung%20cancer%20(SCLC)%20from%20lung%20adenocarcinoma%20(LUAD)&amp;author=T%20Xie&amp;author=Y%20Li&amp;author=J%20Ying&amp;author=W%20Cai&amp;author=J%20Li&amp;volume=9&amp;publication_year=2020&amp;pmid=33489804&amp;doi=10.21037/tlcr-20-1278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Otoshi R, Sekine A, Okudela K, Asaoka M, Sato Y, Ikeda S, et al. Small-cell lung carcinoma transformation of lung adenocarcinoma diagnosed by pericardial effusion: A case report. Mol Clin Oncol. (2020) 13:129–32. doi:  10.3892/mco.2020.2059
</cite> [<a href="https://doi.org/10.3892/mco.2020.2059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7366234/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32714535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Clin%20Oncol&amp;title=Small-cell%20lung%20carcinoma%20transformation%20of%20lung%20adenocarcinoma%20diagnosed%20by%20pericardial%20effusion:%20A%20case%20report&amp;author=R%20Otoshi&amp;author=A%20Sekine&amp;author=K%20Okudela&amp;author=M%20Asaoka&amp;author=Y%20Sato&amp;volume=13&amp;publication_year=2020&amp;pmid=32714535&amp;doi=10.3892/mco.2020.2059&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Hui M, Uppin SG, Stalin BJ, Sadashivudu G. Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature. Lung India. (2018) 35:160–3. doi:  10.4103/lungindia.lungindia_347_17
</cite> [<a href="https://doi.org/10.4103/lungindia.lungindia_347_17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5846268/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29487254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lung%20India&amp;title=Histological%20transformation%20of%20adenocarcinoma%20to%20small%20cell%20carcinoma%20lung%20as%20a%20rare%20mechanism%20of%20resistance%20to%20epidermal%20growth%20factor%20receptor-tyrosine%20kinase%20inhibitors:%20Report%20of%20a%20case%20with%20review%20of%20literature&amp;author=M%20Hui&amp;author=SG%20Uppin&amp;author=BJ%20Stalin&amp;author=G%20Sadashivudu&amp;volume=35&amp;publication_year=2018&amp;pmid=29487254&amp;doi=10.4103/lungindia.lungindia_347_17&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>
Ahn S, Hwang SH, Han J, Choi YL, Lee SH, Ahn JS, et al. Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases. J Pathol Trans Med. (2016) 50:258–63. doi:  10.4132/jptm.2016.04.19
</cite> [<a href="https://doi.org/10.4132/jptm.2016.04.19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4963973/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27160687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pathol%20Trans%20Med&amp;title=Transformation%20to%20Small%20Cell%20Lung%20Cancer%20of%20Pulmonary%20Adenocarcinoma:%20Clinicopathologic%20Analysis%20of%20Six%20Cases&amp;author=S%20Ahn&amp;author=SH%20Hwang&amp;author=J%20Han&amp;author=YL%20Choi&amp;author=SH%20Lee&amp;volume=50&amp;publication_year=2016&amp;pmid=27160687&amp;doi=10.4132/jptm.2016.04.19&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Digiacomo N, De Pas T, Rossi G, Bossi P, Stucchi E, Conforti F, et al. Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review. Curr Oncol. (2023) 30:3494–9. doi:  10.3390/curroncol30030265
</cite> [<a href="https://doi.org/10.3390/curroncol30030265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10047844/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36975478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Oncol&amp;title=Exon-18-EGFR%20Mutated%20Transformed%20Small-Cell%20Lung%20Cancer:%20A%20Case%20Report%20and%20Literature%20Review&amp;author=N%20Digiacomo&amp;author=T%20De%20Pas&amp;author=G%20Rossi&amp;author=P%20Bossi&amp;author=E%20Stucchi&amp;volume=30&amp;publication_year=2023&amp;pmid=36975478&amp;doi=10.3390/curroncol30030265&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
Lyu H-X, Ma WH, Zhang YQ, Jin H, Wang YD, Zhao M. Case report: Emerging therapies for transformed small cell lung cancer: efficacy of serplulimab and a comprehensive case report. Front Med. (2024) 11:1406515. doi:  10.3389/fmed.2024.1406515
</cite> [<a href="https://doi.org/10.3389/fmed.2024.1406515" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11461193/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39386753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Med&amp;title=Case%20report:%20Emerging%20therapies%20for%20transformed%20small%20cell%20lung%20cancer:%20efficacy%20of%20serplulimab%20and%20a%20comprehensive%20case%20report&amp;author=H-X%20Lyu&amp;author=WH%20Ma&amp;author=YQ%20Zhang&amp;author=H%20Jin&amp;author=YD%20Wang&amp;volume=11&amp;publication_year=2024&amp;pages=1406515&amp;pmid=39386753&amp;doi=10.3389/fmed.2024.1406515&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>
Tokaca N, Wotherspoon A, Nicholson AG, Fotiadis N, Thompson L, Popat S. Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer. Lung Cancer. (2017) 111:65–8. doi:  10.1016/j.lungcan.2017.07.012
</cite> [<a href="https://doi.org/10.1016/j.lungcan.2017.07.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28838401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&amp;title=Lack%20of%20response%20to%20nivolumab%20in%20a%20patient%20with%20EGFR-mutant%20non-small%20cell%20lung%20cancer%20adenocarcinoma%20sub-type%20transformed%20to%20small%20cell%20lung%20cancer&amp;author=N%20Tokaca&amp;author=A%20Wotherspoon&amp;author=AG%20Nicholson&amp;author=N%20Fotiadis&amp;author=L%20Thompson&amp;volume=111&amp;publication_year=2017&amp;pmid=28838401&amp;doi=10.1016/j.lungcan.2017.07.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Liu H, Chen LH, Zhang ZH, Wang N, Zhuang SH, Chen H. Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases. Front Oncol. (2022) 12:1022705. doi:  10.3389/fonc.2022.1022705

</cite> [<a href="https://doi.org/10.3389/fonc.2022.1022705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9683475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36439460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Histomorphological%20transformation%20from%20non-small%20cell%20lung%20carcinoma%20to%20small%20cell%20lung%20carcinoma%20after%20targeted%20therapy%20or%20immunotherapy:%20A%20report%20of%20two%20cases&amp;author=H%20Liu&amp;author=LH%20Chen&amp;author=ZH%20Zhang&amp;author=N%20Wang&amp;author=SH%20Zhuang&amp;volume=12&amp;publication_year=2022&amp;pages=1022705&amp;pmid=36439460&amp;doi=10.3389/fonc.2022.1022705&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Wang Y, Li J, Luo L, Li X, Liu Q, Wang Y, et al. Ureteral metastasis of small cell lung cancer transformed from lung adenocarcinoma: A case report. Thorac Cancer. (2022) 13:1731–4. doi:  10.1111/1759-7714.14435
</cite> [<a href="https://doi.org/10.1111/1759-7714.14435" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9161337/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35437882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorac%20Cancer&amp;title=Ureteral%20metastasis%20of%20small%20cell%20lung%20cancer%20transformed%20from%20lung%20adenocarcinoma:%20A%20case%20report&amp;author=Y%20Wang&amp;author=J%20Li&amp;author=L%20Luo&amp;author=X%20Li&amp;author=Q%20Liu&amp;volume=13&amp;publication_year=2022&amp;pmid=35437882&amp;doi=10.1111/1759-7714.14435&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Xue S, Yu T, Zhang Y, Shan L. Clinical Observation of Translating to Small Cell Lung Cancer Following Treatment with EGFR-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma. Zhongguo fei ai za zhi = Chin J Lung Cancer. (2015) 18:656–60. doi:  10.3779/j.issn.1009-3419.2015.10.10
</cite> [<a href="https://doi.org/10.3779/j.issn.1009-3419.2015.10.10" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6000092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26483340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Zhongguo%20fei%20ai%20za%20zhi%20=%20Chin%20J%20Lung%20Cancer&amp;title=Clinical%20Observation%20of%20Translating%20to%20Small%20Cell%20Lung%20Cancer%20Following%20Treatment%20with%20EGFR-Tyrosine%20Kinase%20Inhibitors%20in%20Lung%20Adenocarcinoma&amp;author=S%20Xue&amp;author=T%20Yu&amp;author=Y%20Zhang&amp;author=L%20Shan&amp;volume=18&amp;publication_year=2015&amp;pmid=26483340&amp;doi=10.3779/j.issn.1009-3419.2015.10.10&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Zhang C, Lin L, Guo X, Chen P. Significance of genetic sequencing in patients with lung adenocarcinoma with transformation to small cell lung cancer: a case report and systematic review. Trans Cancer Res. (2020) 9:3725–33. doi:  10.21037/tcr-19-2291
</cite> [<a href="https://doi.org/10.21037/tcr-19-2291" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8798927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35117735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trans%20Cancer%20Res&amp;title=Significance%20of%20genetic%20sequencing%20in%20patients%20with%20lung%20adenocarcinoma%20with%20transformation%20to%20small%20cell%20lung%20cancer:%20a%20case%20report%20and%20systematic%20review&amp;author=C%20Zhang&amp;author=L%20Lin&amp;author=X%20Guo&amp;author=P%20Chen&amp;volume=9&amp;publication_year=2020&amp;pmid=35117735&amp;doi=10.21037/tcr-19-2291&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Lin Q, Cai GP, Yang KY, Yang L, Chen CS, Li YP. Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors. BMC Cancer. (2016) 16:593. doi:  10.1186/s12885-016-2623-4

</cite> [<a href="https://doi.org/10.1186/s12885-016-2623-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4972970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27488410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Case%20report:%20small%20cell%20transformation%20and%20metastasis%20to%20the%20breast%20in%20a%20patient%20with%20lung%20adenocarcinoma%20following%20maintenance%20treatment%20with%20epidermal%20growth%20factor%20receptor%20tyrosine%20kinase%20inhibitors&amp;author=Q%20Lin&amp;author=GP%20Cai&amp;author=KY%20Yang&amp;author=L%20Yang&amp;author=CS%20Chen&amp;volume=16&amp;publication_year=2016&amp;pages=593&amp;pmid=27488410&amp;doi=10.1186/s12885-016-2623-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Chowaniecova G, Berzinec P, Kosturiakova G, Plank L, Farkasova A, Sekeresova M, et al. An EGFR-mutant lung adenocarcinoma that transformed into small-cell lung cancer. A case report. Biomed Pap-Olomouc. (2022) 166:451–4. doi:  10.5507/bp.2022.037
</cite> [<a href="https://doi.org/10.5507/bp.2022.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36036563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Pap-Olomouc&amp;title=An%20EGFR-mutant%20lung%20adenocarcinoma%20that%20transformed%20into%20small-cell%20lung%20cancer.%20A%20case%20report&amp;author=G%20Chowaniecova&amp;author=P%20Berzinec&amp;author=G%20Kosturiakova&amp;author=L%20Plank&amp;author=A%20Farkasova&amp;volume=166&amp;publication_year=2022&amp;pmid=36036563&amp;doi=10.5507/bp.2022.037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
Zhai X, Liu J, Liang Z, Li Z, Liu Y, Huang L, et al. Case Report: Re-Sensitization to Gefitinib in Lung Adenocarcinoma Harboring EGFR Mutation and High PD-L1 Expression After Immunotherapy Resistance, Which Finally Transform Into Small Cell Carcinoma. Front Oncol. (2021) 11:661034. doi:  10.3389/fonc.2021.661034

</cite> [<a href="https://doi.org/10.3389/fonc.2021.661034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8264361/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34249697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Case%20Report:%20Re-Sensitization%20to%20Gefitinib%20in%20Lung%20Adenocarcinoma%20Harboring%20EGFR%20Mutation%20and%20High%20PD-L1%20Expression%20After%20Immunotherapy%20Resistance,%20Which%20Finally%20Transform%20Into%20Small%20Cell%20Carcinoma&amp;author=X%20Zhai&amp;author=J%20Liu&amp;author=Z%20Liang&amp;author=Z%20Li&amp;author=Y%20Liu&amp;volume=11&amp;publication_year=2021&amp;pages=661034&amp;pmid=34249697&amp;doi=10.3389/fonc.2021.661034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Yang M-H, Yu J, Cai CL, Li W. Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report. Front Oncol. (2022) 12:1029282. doi:  10.3389/fonc.2022.1029282

</cite> [<a href="https://doi.org/10.3389/fonc.2022.1029282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9768476/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36568150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Small%20cell%20lung%20cancer%20transformation%20and%20tumor%20heterogeneity%20after%20sequential%20targeted%20therapy%20and%20immunotherapy%20in%20EGFR-mutant%20non-small%20cell%20lung%20cancer:%20A%20case%20report&amp;author=M-H%20Yang&amp;author=J%20Yu&amp;author=CL%20Cai&amp;author=W%20Li&amp;volume=12&amp;publication_year=2022&amp;pages=1029282&amp;pmid=36568150&amp;doi=10.3389/fonc.2022.1029282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Li X, Luan X, Zhang M, Wang R, Guo J, Lv J, et al. Potential therapeutic option for EGFR-mutant small cell lung cancer transformation: a case report and literature review. Front Immunol. (2024) 15:1439033. doi:  10.3389/fimmu.2024.1439033

</cite> [<a href="https://doi.org/10.3389/fimmu.2024.1439033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11371601/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39234244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Potential%20therapeutic%20option%20for%20EGFR-mutant%20small%20cell%20lung%20cancer%20transformation:%20a%20case%20report%20and%20literature%20review&amp;author=X%20Li&amp;author=X%20Luan&amp;author=M%20Zhang&amp;author=R%20Wang&amp;author=J%20Guo&amp;volume=15&amp;publication_year=2024&amp;pages=1439033&amp;pmid=39234244&amp;doi=10.3389/fimmu.2024.1439033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Liu Y. Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review. Cancer Biol Ther. (2018) 19:445–9. doi:  10.1080/15384047.2018.1435222
</cite> [<a href="https://doi.org/10.1080/15384047.2018.1435222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5927699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29461911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Biol%20Ther&amp;title=Small%20cell%20lung%20cancer%20transformation%20from%20EGFR-mutated%20lung%20adenocarcinoma:%20A%20case%20report%20and%20literatures%20review&amp;author=Y%20Liu&amp;volume=19&amp;publication_year=2018&amp;pmid=29461911&amp;doi=10.1080/15384047.2018.1435222&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>
Marcoux N, Gettinger SN, O'Kane G, Arbour KC, Neal JW, Husain H, et al. EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes. J Clin Oncol. (2018) 37:278–85. doi:  10.1200/JCO.18.01585
</cite> [<a href="https://doi.org/10.1200/JCO.18.01585" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7001776/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30550363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=EGFR-Mutant%20Adenocarcinomas%20That%20Transform%20to%20Small-Cell%20Lung%20Cancer%20and%20Other%20Neuroendocrine%20Carcinomas:%20Clinical%20Outcomes&amp;author=N%20Marcoux&amp;author=SN%20Gettinger&amp;author=G%20O'Kane&amp;author=KC%20Arbour&amp;author=JW%20Neal&amp;volume=37&amp;publication_year=2018&amp;pmid=30550363&amp;doi=10.1200/JCO.18.01585&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>
Offin M, Chan JM, Tenet M, Rizvi HA, Shen R, Riely GJ, et al. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes. J Thorac Oncol. (2019) 14:1784–93. doi:  10.1016/j.jtho.2019.06.002
</cite> [<a href="https://doi.org/10.1016/j.jtho.2019.06.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6764905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31228622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Concurrent%20RB1%20and%20TP53%20Alterations%20Define%20a%20Subset%20of%20EGFR-Mutant%20Lung%20Cancers%20at%20risk%20for%20Histologic%20Transformation%20and%20Inferior%20Clinical%20Outcomes&amp;author=M%20Offin&amp;author=JM%20Chan&amp;author=M%20Tenet&amp;author=HA%20Rizvi&amp;author=R%20Shen&amp;volume=14&amp;publication_year=2019&amp;pmid=31228622&amp;doi=10.1016/j.jtho.2019.06.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Kondoh C, Horio Y, Hayashi Y, Ebi H, Hida T, Hasegawa Y, et al. Anaplastic lymphoma kinase expression in small-cell lung cancer. Histopathology. (2019) 75:20–8. doi:  10.1111/his.13842
</cite> [<a href="https://doi.org/10.1111/his.13842" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30790327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Histopathology&amp;title=Anaplastic%20lymphoma%20kinase%20expression%20in%20small-cell%20lung%20cancer&amp;author=C%20Kondoh&amp;author=Y%20Horio&amp;author=Y%20Hayashi&amp;author=H%20Ebi&amp;author=T%20Hida&amp;volume=75&amp;publication_year=2019&amp;pmid=30790327&amp;doi=10.1111/his.13842&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Norkowski E, Ghigna MR, Lacroix L, Le Chevalier T, Fadel É, Dartevelle P, et al. Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology. J Thorac Oncol. (2013) 8:1265–71. doi:  10.1097/JTO.0b013e3182a407fa
</cite> [<a href="https://doi.org/10.1097/JTO.0b013e3182a407fa" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24457237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Small-cell%20carcinoma%20in%20the%20setting%20of%20pulmonary%20adenocarcinoma:%20new%20insights%20in%20the%20era%20of%20molecular%20pathology&amp;author=E%20Norkowski&amp;author=MR%20Ghigna&amp;author=L%20Lacroix&amp;author=T%20Le%20Chevalier&amp;author=%C3%89%20Fadel&amp;volume=8&amp;publication_year=2013&amp;pmid=24457237&amp;doi=10.1097/JTO.0b013e3182a407fa&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Niederst MJ, Sequist LV, Poirier JT, Mermel CH, Lockerman EL, Garcia AR, et al. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer. Nat Commun. (2015) 6:6377. doi:  10.1038/ncomms7377

</cite> [<a href="https://doi.org/10.1038/ncomms7377" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4357281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25758528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=RB%20loss%20in%20resistant%20EGFR%20mutant%20lung%20adenocarcinomas%20that%20transform%20to%20small-cell%20lung%20cancer&amp;author=MJ%20Niederst&amp;author=LV%20Sequist&amp;author=JT%20Poirier&amp;author=CH%20Mermel&amp;author=EL%20Lockerman&amp;volume=6&amp;publication_year=2015&amp;pages=6377&amp;pmid=25758528&amp;doi=10.1038/ncomms7377&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Giaccone G, He Y. Current knowledge of small cell lung cancer transformation from non-small cell lung cancer. Semin Cancer Biol. (2023) 94:1–10. doi:  10.1016/j.semcancer.2023.05.006

</cite> [<a href="https://doi.org/10.1016/j.semcancer.2023.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37244438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Semin%20Cancer%20Biol&amp;title=Current%20knowledge%20of%20small%20cell%20lung%20cancer%20transformation%20from%20non-small%20cell%20lung%20cancer&amp;author=G%20Giaccone&amp;author=Y%20He&amp;volume=94&amp;publication_year=2023&amp;pages=1-10&amp;pmid=37244438&amp;doi=10.1016/j.semcancer.2023.05.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Hirsch FR, Bunn PA.
EGFR testing in lung cancer is ready for prime time. Lancet Oncol. (2009) 10:432–3. doi:  10.1016/S1470-2045(09)70110-X
</cite> [<a href="https://doi.org/10.1016/S1470-2045(09)70110-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19410185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=EGFR%20testing%20in%20lung%20cancer%20is%20ready%20for%20prime%20time&amp;author=FR%20Hirsch&amp;author=PA%20Bunn&amp;volume=10&amp;publication_year=2009&amp;pmid=19410185&amp;doi=10.1016/S1470-2045(09)70110-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Wang S, Xie T, Hao X, Wang Y, Hu X, Wang L, et al. Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma. Thorac Cancer. (2021) 12:2585–93. doi:  10.1111/1759-7714.14144
</cite> [<a href="https://doi.org/10.1111/1759-7714.14144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8487822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34490724/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorac%20Cancer&amp;title=Comprehensive%20analysis%20of%20treatment%20modes%20and%20clinical%20outcomes%20of%20small%20cell%20lung%20cancer%20transformed%20from%20epidermal%20growth%20factor%20receptor%20mutant%20lung%20adenocarcinoma&amp;author=S%20Wang&amp;author=T%20Xie&amp;author=X%20Hao&amp;author=Y%20Wang&amp;author=X%20Hu&amp;volume=12&amp;publication_year=2021&amp;pmid=34490724&amp;doi=10.1111/1759-7714.14144&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Wang W, Xu C, Chen H, Jia J, Wang L, Feng H, et al. Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study. Lung Cancer. (2021) 155:20–7. doi:  10.1016/j.lungcan.2021.03.006
</cite> [<a href="https://doi.org/10.1016/j.lungcan.2021.03.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33714778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&amp;title=Genomic%20alterations%20and%20clinical%20outcomes%20in%20patients%20with%20lung%20adenocarcinoma%20with%20transformation%20to%20small%20cell%20lung%20cancer%20after%20treatment%20with%20EGFR%20tyrosine%20kinase%20inhibitors:%20A%20multicenter%20retrospective%20study&amp;author=W%20Wang&amp;author=C%20Xu&amp;author=H%20Chen&amp;author=J%20Jia&amp;author=L%20Wang&amp;volume=155&amp;publication_year=2021&amp;pmid=33714778&amp;doi=10.1016/j.lungcan.2021.03.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Tomic K, Krpina K, Baticic L, Samarzija M, Vranic S. Comprehensive molecular and clinical insights into non-small cell lung cancer transformation to small cell lung cancer with an illustrative case report. J Drug Targeting. (2024) 32:499–509. doi:  10.1080/1061186X.2024.2332733
</cite> [<a href="https://doi.org/10.1080/1061186X.2024.2332733" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38506620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Drug%20Targeting&amp;title=Comprehensive%20molecular%20and%20clinical%20insights%20into%20non-small%20cell%20lung%20cancer%20transformation%20to%20small%20cell%20lung%20cancer%20with%20an%20illustrative%20case%20report&amp;author=K%20Tomic&amp;author=K%20Krpina&amp;author=L%20Baticic&amp;author=M%20Samarzija&amp;author=S%20Vranic&amp;volume=32&amp;publication_year=2024&amp;pages=499-509&amp;pmid=38506620&amp;doi=10.1080/1061186X.2024.2332733&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Iams WT, Beckermann KE, Almodovar K, Hernandez J, Vnencak-Jones C, Lim LP, et al. Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases. J Thorac Oncol. (2018) 14:e45–8. doi:  10.1016/j.jtho.2018.11.031
</cite> [<a href="https://doi.org/10.1016/j.jtho.2018.11.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6382512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30543839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Small%20Cell%20Lung%20Cancer%20Transformation%20as%20a%20Mechanism%20of%20Resistance%20to%20PD-1%20Therapy%20in%20KRAS-Mutant%20Lung%20Adenocarcinoma:%20A%20Report%20of%20Two%20Cases&amp;author=WT%20Iams&amp;author=KE%20Beckermann&amp;author=K%20Almodovar&amp;author=J%20Hernandez&amp;author=C%20Vnencak-Jones&amp;volume=14&amp;publication_year=2018&amp;pmid=30543839&amp;doi=10.1016/j.jtho.2018.11.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>
Zhang C-Y, Sun H, Su JW, Chen YQ, Zhang SL, Zheng MY, et al. A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival. Lung Cancer (Amsterdam Netherlands). (2023) 175:68–78. doi:  10.1016/j.lungcan.2022.11.016

</cite> [<a href="https://doi.org/10.1016/j.lungcan.2022.11.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36473332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer%20(Amsterdam%20Netherlands)&amp;title=A%20potential%20treatment%20option%20for%20transformed%20small-cell%20lung%20cancer%20on%20PD-L1%20inhibitor-based%20combination%20therapy%20improved%20survival&amp;author=C-Y%20Zhang&amp;author=H%20Sun&amp;author=JW%20Su&amp;author=YQ%20Chen&amp;author=SL%20Zhang&amp;volume=175&amp;publication_year=2023&amp;pages=68-78&amp;pmid=36473332&amp;doi=10.1016/j.lungcan.2022.11.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Oncology are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fonc.2025.1573624"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fonc-15-1573624.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (5.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12003138/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12003138/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12003138%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12003138/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12003138/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12003138/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40248195/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12003138/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40248195/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12003138/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12003138/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Zuy3njdSzH169EC7nulxNABH4cpvCXrV2kLUauLHj4kTa9Fr5XHARgnlXBJzICkD">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
